text: Source: [https://scheringstiftung.de/en/programm/lebenswissenschaften/ernst-schering-preis/ Schering Foundation]
  *1992 , (Center for Molecular Biology, University of Heidelberg, Germany)
  *1993 Christiane Nüsslein-Volhard, (Max Planck Institute for Developmental Biology in Tübingen, Germany)
  *1994 Bert Vogelstein, (Oncology Center, Johns Hopkins University, Baltimore, Maryland, US)
  *1995 Yasutomi Nishizuka, (Kobe University, Japan)
  *1996 Judah Folkman, (Harvard Medical School, Harvard University, Boston, US)
  *1997 Johann Mulzer, (Institute for Organic Chemistry, University of Vienna, Austria)
  *1998 Ilme Schlichting, (Max Planck Institute for Molecular Physiology in Dortmund, Germany)
  *1999 Michael Berridge, (Babraham Institute in Cambridge, UK)
  *2000 , (University of Tokyo, Japan)
  *2001 Kyriacos Nicolaou, (University of California, San Diego, California, and The Scripps Research Institute, La Jolla, California, US)
  *2002 Ian Wilmut, (The Roslin Institute in Edinburgh, UK)
  *2003 Svante Pääbo, (Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany)
  *2004 , (National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, US)
  *2005 Thomas Tuschl, (Laboratory of RNA Molecular Biology, Rockefeller University, New York)
  *2006 Wolfgang Baumeister, (Max Planck Institute of Biochemistry in Martinsried, Germany) 
  *2007 Carolyn Bertozzi, (University of California, Berkeley, US)
  *2008 Klaus Rajewsky, (Harvard Medical School, Boston, US)
  *2009 Rudolf Jaenisch, (Whitehead Institute, Cambridge, Massachusetts, US)
  *2010 Marc Feldmann and Sir Ravinder Maini, (Kennedy Institute of Rheumatology at Imperial College London, UK)
  *2011 Bert W. O'Malley, (Tom Thompson Distinguished Service Professor and Chair of Molecular and Cellular Biology at Baylor College of Medicine in Houston, Texas)
  *2012 Matthias Mann, (Max Planck Institute of Biochemistry in Martinsried, Germany)
  *2013 , (Institute of Molecular Virology at the Ulm University Medical Center in Ulm, Germany)
  *2014 Magdalena Götz, (Director of the Institute of Stem Cell Research at the Helmholtz Zentrum München and chair of Physiological Genomics at the University of Munich (LMU) in Munich, Germany)
  *2015 David MacMillan, (Professor of Chemistry at Princeton University, US).
  *2016 Franz-Ulrich Hartl, (Max Planck Institute of Biochemistry in Martinsried, Germany).
  *2017 Elly Tanaka, (Senior Scientist at Research Institute of Molecular Pathology in Vienna, Austria)
  *2018 Bonnie L. Bassler, (Princeton University, New Jersey)
  *2019 Patrick Cramer, (Director at the Max Planck Institute for Biophysical Chemistry in Göttingen)
  *2020 , (Director at the ( in Cologne)
  *2021 Aviv Regev, (Head of Genentech Research and Early Development in South San Francisco, US)
  *2022  (Professor of Computer-Assisted Drug Design at the Institute of Pharmaceutical Sciences at ETH Zurich and director of the Singapore-ETH Center)
  *2023 Matthias Tschöp (CEO and scientific director at Helmholtz Zentrum München, Germany. Alexander von Humboldt Professor at the Technical University of Munich (TUM), and Helmholtz Vice President of Health Research